8-38146269-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000349.3(STAR):​c.465+20A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.985 in 1,614,026 control chromosomes in the GnomAD database, including 783,079 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.98 ( 72617 hom., cov: 31)
Exomes 𝑓: 0.99 ( 710462 hom. )

Consequence

STAR
NM_000349.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0580

Publications

6 publications found
Variant links:
Genes affected
STAR (HGNC:11359): (steroidogenic acute regulatory protein) The protein encoded by this gene plays a key role in the acute regulation of steroid hormone synthesis by enhancing the conversion of cholesterol into pregnenolone. This protein permits the cleavage of cholesterol into pregnenolone by mediating the transport of cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane. Mutations in this gene are a cause of congenital lipoid adrenal hyperplasia (CLAH), also called lipoid CAH. A pseudogene of this gene is located on chromosome 13. [provided by RefSeq, Jul 2008]
STAR Gene-Disease associations (from GenCC):
  • congenital lipoid adrenal hyperplasia due to STAR deficency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 8-38146269-T-C is Benign according to our data. Variant chr8-38146269-T-C is described in ClinVar as Benign. ClinVar VariationId is 448532.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.984 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000349.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STAR
NM_000349.3
MANE Select
c.465+20A>G
intron
N/ANP_000340.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STAR
ENST00000276449.9
TSL:1 MANE Select
c.465+20A>G
intron
N/AENSP00000276449.3
STAR
ENST00000522050.1
TSL:5
c.399+20A>G
intron
N/AENSP00000429009.1
STAR
ENST00000520114.1
TSL:2
n.952+20A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.976
AC:
148547
AN:
152158
Hom.:
72569
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.946
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.987
Gnomad ASJ
AF:
0.976
Gnomad EAS
AF:
0.995
Gnomad SAS
AF:
0.935
Gnomad FIN
AF:
0.994
Gnomad MID
AF:
0.991
Gnomad NFE
AF:
0.990
Gnomad OTH
AF:
0.981
GnomAD2 exomes
AF:
0.981
AC:
246568
AN:
251294
AF XY:
0.980
show subpopulations
Gnomad AFR exome
AF:
0.946
Gnomad AMR exome
AF:
0.993
Gnomad ASJ exome
AF:
0.977
Gnomad EAS exome
AF:
0.997
Gnomad FIN exome
AF:
0.994
Gnomad NFE exome
AF:
0.990
Gnomad OTH exome
AF:
0.981
GnomAD4 exome
AF:
0.986
AC:
1440978
AN:
1461750
Hom.:
710462
Cov.:
57
AF XY:
0.985
AC XY:
716129
AN XY:
727178
show subpopulations
African (AFR)
AF:
0.944
AC:
31603
AN:
33480
American (AMR)
AF:
0.991
AC:
44322
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.979
AC:
25592
AN:
26136
East Asian (EAS)
AF:
0.989
AC:
39281
AN:
39700
South Asian (SAS)
AF:
0.938
AC:
80875
AN:
86258
European-Finnish (FIN)
AF:
0.994
AC:
52943
AN:
53286
Middle Eastern (MID)
AF:
0.981
AC:
5659
AN:
5768
European-Non Finnish (NFE)
AF:
0.990
AC:
1101419
AN:
1112002
Other (OTH)
AF:
0.982
AC:
59284
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
1244
2487
3731
4974
6218
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21666
43332
64998
86664
108330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.976
AC:
148652
AN:
152276
Hom.:
72617
Cov.:
31
AF XY:
0.976
AC XY:
72697
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.946
AC:
39305
AN:
41546
American (AMR)
AF:
0.987
AC:
15092
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.976
AC:
3390
AN:
3472
East Asian (EAS)
AF:
0.995
AC:
5140
AN:
5166
South Asian (SAS)
AF:
0.934
AC:
4505
AN:
4824
European-Finnish (FIN)
AF:
0.994
AC:
10567
AN:
10626
Middle Eastern (MID)
AF:
0.990
AC:
291
AN:
294
European-Non Finnish (NFE)
AF:
0.990
AC:
67378
AN:
68028
Other (OTH)
AF:
0.980
AC:
2072
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
183
366
550
733
916
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.982
Hom.:
13991
Bravo
AF:
0.976
Asia WGS
AF:
0.934
AC:
3251
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
Jul 27, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital lipoid adrenal hyperplasia due to STAR deficency Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
8.0
DANN
Benign
0.34
PhyloP100
0.058
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2720050; hg19: chr8-38003787; API